Similar articles for PMID: 18077536

Year	Number of Results
1999	1
2002	2
2003	4
2004	5
2005	3
2006	5
2007	6
2008	4
2009	11
2010	8
2011	15
2012	4
2013	12
2014	9
2015	9
2016	8
2017	8
2018	8
2019	7
2020	6
2021	4
2022	2
2023	1
2024	0

1

PET imaging of VPAC1 expression in experimental and spontaneous prostate cancer.

Zhang K, Aruva MR, Shanthly N, Cardi CA, Rattan S, Patel C, Kim C, McCue PA, Wickstrom E, Thakur ML. Zhang K, et al. J Nucl Med. 2008 Jan;49(1):112-21. doi: 10.2967/jnumed.107.043703. Epub 2007 Dec 12. J Nucl Med. 2008. PMID: 18077536 Free PMC article.

2

PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog.

Thakur ML, Aruva MR, Gariepy J, Acton P, Rattan S, Prasad S, Wickstrom E, Alavi A. Thakur ML, et al. J Nucl Med. 2004 Aug;45(8):1381-9. J Nucl Med. 2004. PMID: 15299065 Free PMC article.

3

microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.

Chen X, Park R, Hou Y, Tohme M, Shahinian AH, Bading JR, Conti PS. Chen X, et al. J Nucl Med. 2004 Aug;45(8):1390-7. J Nucl Med. 2004. PMID: 15299066 Free article.

4

Targeting VPAC1 Receptors for Imaging Glioblastoma.

Tripathi SK, Kean R, Bongiorno E, Hooper DC, Jin YY, Wickstrom E, McCue PA, Thakur ML. Tripathi SK, et al. Mol Imaging Biol. 2020 Apr;22(2):293-302. doi: 10.1007/s11307-019-01388-5. Mol Imaging Biol. 2020. PMID: 31292914

5

HSDAVFTDNYTKLRKQ-NIe-AVKK-(3-OCH3,4-OH)-FLNSSV-GABA-L-(Dap-(BMA)₂)-⁶⁴Cu.

Cheng KT, Thakur ML. Cheng KT, et al. 2008 Mar 17 [updated 2008 Jun 11]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2008 Mar 17 [updated 2008 Jun 11]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641421 Free Books & Documents. Review.

6

Imaging spontaneous MMTVneu transgenic murine mammary tumors: targeting metabolic activity versus genetic products.

Thakur ML, Devadhas D, Zhang K, Pestell RG, Wang C, McCue P, Wickstrom E. Thakur ML, et al. J Nucl Med. 2010 Jan;51(1):106-11. doi: 10.2967/jnumed.109.069542. Epub 2009 Dec 15. J Nucl Med. 2010. PMID: 20008985 Free article.

7

Preclinical evaluation of a ⁶⁴Cu-labeled disintegrin for PET imaging of prostate cancer.

Jadvar H, Chen K, Park R, Yap LP, Vorobyova I, Swenson S, Markland FS. Jadvar H, et al. Amino Acids. 2019 Nov;51(10-12):1569-1575. doi: 10.1007/s00726-019-02794-3. Epub 2019 Oct 16. Amino Acids. 2019. PMID: 31621030 Free PMC article.

8

Reduced 64Cu uptake and tumor growth inhibition by knockdown of human copper transporter 1 in xenograft mouse model of prostate cancer.

Cai H, Wu JS, Muzik O, Hsieh JT, Lee RJ, Peng F. Cai H, et al. J Nucl Med. 2014 Apr;55(4):622-8. doi: 10.2967/jnumed.113.126979. Epub 2014 Mar 17. J Nucl Med. 2014. PMID: 24639459 Free PMC article.

9

Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.

Carlos Dos Santos J, Beijer B, Bauder-Wüst U, Schäfer M, Leotta K, Eder M, Benešová M, Kleist C, Giesel F, Kratochwil C, Kopka K, Haberkorn U, Mier W. Carlos Dos Santos J, et al. J Nucl Med. 2020 Jan;61(1):70-79. doi: 10.2967/jnumed.119.229054. Epub 2019 Sep 20. J Nucl Med. 2020. PMID: 31541034 Free article.

10

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

122 results

Results by year